-
NVDIAG LabCom
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
509 -
Activities
-
Technologies
-
Entity types
-
Location
31 Chem. Joseph Aiguier, 13009 Marseille, France
Marseille
France
-
Employees
Scale: 2-10
Estimated: 18
-
Engaged catalyst
17
0 0 -
Added in Motherbase
7 months, 2 weeks ago
-
Value proposition
[Automatic translation follows] The innovation of nano-antibodies in the service of medical diagnosis. A strategic alliance between LISM and BioCytex.
NVDIAG — acronym for Nano-antibody generation using extracellular Vesicles for DIAgnostic purposes — is a joint laboratory (LabCom) born from a bilateral partnership between the Laboratory of Macromolecular Systems Engineering (LISM) and the company BioCytex, both located in Marseille. NVDIAG plays a leading role in hemato-oncology innovation, focusing on the development of camelid monoclonal antibodies (nanoantibodies) for a broad range of tests and companion diagnostic solutions. This work benefited from support from the French government under France 2030, as part of the Aix-Marseille University Excellence Initiative – AMIDEX -
Original language
L'innovation des nano-anticorps au service du diagnostic médical. Une alliance stratégique entre le LISM et BioCytex.
NVDIAG — acronyme de Nano-antibody generation using extracellular Vesicles for DIAgnostic purposes — est un laboratoire commun (LabCom) né d’un partenariat bilatéral entre le Laboratoire d’Ingénierie des Systèmes Macromoléculaires (LISM) et l'entreprise BioCytex, tous deux implantés à Marseille. NVDIAG joue un rôle de premier plan dans l'innovation en hémato-oncologie, en se concentrant sur le développement d'anticorps monoclonaux de camélidés (nano-anticorps) destinés à une large gamme de tests et de solutions de diagnostic compagnon. Ce travail a bénéficié d'une aide du gouvernement français au titre de France 2030, dans le cadre de l'Initiative d'Excellence d'Aix-Marseille Université – AMIDEX
-
NVDIAG - Innovative nano-antibodies for medical diagnostics
Innovative nano-antibodies for medical diagnostics
https://nvdiag-labcom.fr/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Genopole
Biotechnology, Biotechnology Research (Auto) |
Genopole
Biotechnology, Biotechnology Research (Auto) |
Other
28 Oct 2026 |
|
|
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research (Auto) |
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research (Auto) |
Other
28 Oct 2026 |
|
|
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Non-profit Organizations (Auto) |
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Non-profit Organizations (Auto) |
Other
28 Oct 2026 |
|
|
CNRS Innovation
Research, Research (Auto) |
CNRS Innovation
Research, Research (Auto) |
Other
28 Oct 2026 |
|
|
Cité de l'Innovation et des Savoirs Aix-Marseille
Startup accelerator & VC, Higher Education (Auto) |
Cité de l'Innovation et des Savoirs Aix-Marseille
Startup accelerator & VC, Higher Education (Auto) |
Other
28 Oct 2026 |
|
|
IRD
Research Services (Auto) |
IRD
Research Services (Auto) |
Other
19 Apr 2026 |
|
|
INRAE
Research, Research Services (Auto) |
INRAE
Research, Research Services (Auto) |
Other
19 Apr 2026 |
|
|
CNRS
Research, Research Services (Auto) |
CNRS
Research, Research Services (Auto) |
Other
28 Oct 2026 |
|
|
Région Sud - Provence-Alpes-Côte d'Azur
National and local authorities, Government Administration (Auto) |
Région Sud - Provence-Alpes-Côte d'Azur
National and local authorities, Government Administration (Auto) |
Other
28 Oct 2026 |
|
|
Amgen
Biotechnology, Biotechnology Research (Auto) |
Amgen
Biotechnology, Biotechnology Research (Auto) |
Other
31 Jan 2026 |
|
|